Nanocomposites of graphene and cytochrome P450 2D6 isozyme for electrochemical-driven tramadol metabolism

Langmuir

Volumn 30, Issue 39, 2014, Pages 11833-11840

  Cui, Dongmei ^a   Mi, Li ^a   Xu, Xuan ^a   Lu, Jusheng ^a   Qian, Jing ^a   Liu, Songqin ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; TRAMADOL;

CYTOCHROME P450 2D6; CYTOCHROME P450 2D6 INHIBITOR; GRAPHITE; IMMOBILIZED ENZYME; ISOENZYME; NANOCOMPOSITE; POLYETHYLENEIMINE; QUINIDINE; TRAMADOL;

ANTAGONISTS AND INHIBITORS; BIOCATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; ELECTROCHEMISTRY; ELECTRODE; ELECTRON TRANSPORT; METABOLISM; PROTEIN CONFORMATION;

BIOCATALYSIS; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 CYP2D6 INHIBITORS; ELECTROCHEMISTRY; ELECTRODES; ELECTRON TRANSPORT; ENZYMES, IMMOBILIZED; GRAPHITE; ISOENZYMES; MODELS, MOLECULAR; NANOCOMPOSITES; POLYETHYLENEIMINE; PROTEIN CONFORMATION; QUINIDINE; TRAMADOL;

EID: 84907895564     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la502699m     Document Type: Article

References (47)

1. Krishnan, S.; Schenkman, J. B.; Rusling, J. F. Bioelectronic delivery of electrons to cytochrome P450 enzymes J. Phys. Chem. B 2011, 115, 8371-8380
2. Gilardi, G.; Fantuzzi, A.; Sadeghi, S. J. Engineering and design in the bioelectrochemistry of metalloproteins Curr. Opin. Struc. Biol. 2001, 11, 491-499
3. Evans, W. E.; Relling, M. V. Pharmacogenomics: Translating functional genomics into rational therapeutics Science 1999, 286, 487-491
4. Willner, B.; Katz, E.; Willner, I. Electrical contacting of redox proteins by nanotechnological means Curr. Opin. Biotechnol. 2006, 17, 589-596
5. Mie, Y.; Suzuki, M.; Komatsu, Y. Electrochemically driven drug metabolism by membranes containing human cytochrome P450 J. Am. Chem. Soc. 2009, 131, 6646-6647
6. Bistolas, N.; Wollenbergera, U.; Jung, C.; Scheller, F. W. Cytochrome P450 biosensors - A review Biosens. Bioelectron 2005, 20, 2408-2423
7. Kazlauskaite, J.; Westlake, A. C. G.; Wong, L. L.; Hill, H. A. O. Direct electrochemistry of cytochrome P450cam Chem. Commun. 1996, 2189-2190
8. Krishnan, S.; Wasalathanthri, D.; Zhao, L. L.; Schenkman, J. B.; Rusling, J. F. Efficient bioelectronic actuation of the natural catalytic pathway of human metabolic cytochrome P450s J. Am. Chem. Soc. 2011, 133, 1459-1465
9. Ferrero, V. E. V.; Andolfi, L.; Nardo, D. G.; Sadeghi, S. J.; Fantuzzi, A.; Cannistraro, S.; Gilardi, G. Protein and electrode engineering for the covalent immobilization of P450 BMP on gold Anal. Chem. 2008, 80, 8438-8446
10. BM3 measured by direct methods Eur. J. Biochem. 2003, 270, 4082-4088
11. Estavillo, C.; Lu, Z.; Jansson, I.; Schenkman, J. B.; Rusling, J. F. Epoxidation of styrene by human cyt P450 1A2 by thin film electrolysis and peroxide activation compared to solution reactions Biophys. Chem. 2003, 104, 291-296
12. Joseph, S.; Rusling, J. F.; Lvov, Y. M.; Friedberg, T.; Fuhr, U. An amperometric biosensor with human CYP3A4 as a novel drug screening tool Biochem. Pharmacol. 2003, 65, 1817-1826
13. Xue, Q.; Kato, D.; Kamata, T.; Guo, Q. H.; You, T. Y.; Niwa, O. Human cytochrome P450 3A4 and a carbon nanofiber modified film electrode as a platform for the simple evaluation of drug metabolism and inhibition reactions Analyst 2013, 138, 6463-6468
14. Peng, L.; Yang, X. D.; Zhang, Q. Q.; Liu, S. Q. Electrochemistry of cytochrome P450 2B6 on electrodes modified with zirconium dioxide nanoparticles and platin components Electroanal. 2008, 20, 803-807
15. Liu, S. Q.; Peng, L.; Yang, X. D.; Wu, Y. F.; He, L. Electrochemistry of cytochrome P450 enzyme on nanoparticle-containing membrane-coated electrode and its applications for drug sensing Anal. Biochem. 2008, 375, 209-216
16. Xu, X.; Wei, W.; Huang, M. H.; Yao, L.; Liu, S. Q. Electrochemically driven drug metabolism via cytochrome P450 2C9 isozyme microsomes with cytochrome P450 reductase and indium tin oxide nanoparticle composites Chem. Commun. 2012, 48, 7802-7804
17. Huang, M. H.; Xu, X.; Yang, H.; Liu, S. Q. Electrochemically-driven and dynamic enhancement of drug metabolism via cytochrome P450 microsomes on colloidal gold/graphene nanocomposites RSC Adv. 2012, 2, 12844-12850
18. Ma, J. K.; Wang, X. R.; Liu, Y.; Wu, T.; Liu, Y.; Guo, Y. Q.; Li, R. Q.; Sun, X. Y.; Wu, F.; Li, C. B.; Gao, J. P. Reduction of graphene oxide with l -lysine to prepare reduced graphene oxide stabilized with polysaccharide polyelectrolyte J. Mater. Chem. A 2013, 1, 2192-2201
19. Liu, H. Y.; Kuila, T.; Kim, N. H.; Ku, B. C.; Lee, J. H. In situ synthesis of the reduced graphene oxide-polyethyleneimine composite and its gas barrier properties J. Mater. Chem. A 2013, 1, 3739-3746
20. Wen, S. H.; Zheng, F. Y.; Shen, M. W.; Shi, X. Y. Surface modification and PEGylation of branched polyethyleneimine for improved biocompatibility J. Appl. Polym. Sci. 2013, 128, 3807-3813
21. Lu, J. S.; Wei, W.; Yin, L. H.; Pu, Y. P.; Liu, S. Q. Flow injection chemiluminescence immunoassay of microcystin-LR by using PEI-modified magnetic beads as capturer and HRP-functionalized silica nanoparticles as signal amplifier Analyst 2013, 138, 1483-1489
22. Dorne, J. L. C. M.; Walton, K.; Slob, W.; Renwick, A. G. Human variability in polymorphic CYP2D6 metabolism: Is the kinetic default uncertainty factor adequate? Food Chem. Toxicol. 2002, 40, 1633-1656
23. Gaedigk, A.; Blum, M.; Gaedigk, R.; Eichelbaum, M.; Meyer, U. A. Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism Am. J. Hum. Genet. 1991, 48, 943-950
24. Marzo, A.; Balant, L. P. Investigation of xenobiotic metabolism by CYP2D6 and CYP2C19: Importance of enantioselective analytical methods J. Chromatogr. B 1996, 678, 73-92
25. Gan, X. X.; Yuan, R.; Chai, Y. Q.; Yuan, Y. L.; Cao, Y. L.; Liao, Y. H.; Liu, H. J. 3,4,9,10-Perylenetetracarboxylic dianhydride functionalized graphene sheet as labels for ultrasensitive electrochemiluminescent detection of thrombin Anal. Chim. Acta 2012, 726, 67-72
26. Laviron, E. General expression of the linear potential sweep voltammogram in the case of diffusionless electrochemical systems J. Electroanal. Chem. 1979, 101, 19-28
27. Castrignano, S.; Ortolani, A.; Sadeghi, S. J.; Nardo, G. D.; Allegr, P.; Gilardi, G. Electrochemical detection of human cytochrome P450 2A6 inhibition: A step toward reducing dependence on smoking Anal. Chem. 2014, 86, 2760-2766
28. Rusling, J. F.; Hvastkovs, E. G.; Hull, D. O.; Schenkman, J. B. Biochemical applications of ultrathin films of enzymes, polyions and DNA Chem. Commun. 2008, 141-154
29. Subraahmanyam, V.; Renwick, A. B.; Walters, D. G.; Young, P. J.; Price, R. J.; Tonelli, A. P.; Lake, B. G. Identification of cytochrome P-450 isoforms responsible for cis -tramadol metabolism in human liver microsomes Drug Metab. Dispos. 2001, 29, 1146-1155
30. Kamin, R. A.; Wilson, G. S. Rotating ring-disk enzyme electrode for biocatalysis kinetic studies and characterization of the immobilized enzyme layer Anal. Chem. 1980, 52, 1198-1205
31. Malitesta, C.; Palmisano, F.; Torsi, L.; Zambonin, P. G. Glucose fast-response amperometric sensor based on glucose oxidase immobilized in an electropolymerized poly(o -phenylenediamine) film Anal. Chem. 1990, 62, 2735-2740
32. Fantuzzi, A.; Mak, L. H.; Capria, E.; Dodhia, V.; Panicco, P.; Collins, S.; Gilardi, G. A new standardized electrochemical array for drug metabolic profiling with human cytochromes P450 Anal. Chem. 2011, 83, 3831-3839
33. Liu, R. L.; Wu, D. Q.; Feng, X. L.; Müllen, K. Nitrogen-doped ordered mesoporous graphitic arrays with high electrocatalytic activity for oxygen reduction Angew. Chem., Int. Ed. 2010, 122, 2619-2623
34. Raffa, R. B.; S, D. J., Jr. Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice J. Pharmacol. Exp. Ther. 2008, 325, 500-506
35. Mak, L. H.; Sadeghi, S. J.; Fantuzzi, A.; Gilardi, G. Control of human cytochrome P450 2E1 electrocatalytic response as a result of unique orientation on gold electrodes Anal. Chem. 2010, 82, 5357-5362
36. Bertelsen, K. M.; Venkatakrishnan, K.; Moltke, L. L. V.; Obach, R. S.; Greenblatt, D. J. Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: Comparison with fluoxetine and quinidine Drug Metab. Dispos. 2003, 31, 289-293
37. Madani, S.; Paine, M. F.; Lewis, L.; Thummel, K. E.; Shen, D. D. Comparison of CYP2D6 content and metoprolol oxidation between microsomes isolated from human livers and small intestines Pharm. Res. 1999, 16, 1199-1205
38. Kaila, N.; Straka, R. J.; Brundage, R. C. Mixture models and subpopulation classification: A pharmacokinetic simulation study and application to metoprolol CYP2D6 phenotype J. Pharmacokinet. Phar. 2007, 34, 141-156
39. Hanioka, N.; Okumura, Y.; Saito, Y.; Hichiya, H.; Soyama, A.; Saito, K.; Ueno, K.; Sawada, J.; Sawada, J.; Narimatsu, S. Catalytic roles of CYP2D6.10 and CYP2D6.36 enzymes in mexiletine metabolism: In vitro functional analysis of recombinant proteins expressed in Saccharomyces cerevisiae Biochem. Pharmacol. 2006, 71, 1386-1395
40. Vandamme, N.; Broly, F.; Libersa, C.; Courseau, C.; Lhermitte, M. Stereoselective hydroxylation of mexiletine in human liver microsomes: Implication of P450IID6-A preliminary report J. Cardiovasc. Pharm. 1993, 21, 77-83
41. Yu, J. L.; Paine, M. J. I.; Maréchal, J. D.; Kemp, C. A.; Ward, C. J.; Brown, S.; Sutcliffe, M. J.; Roberts, G. C. K.; Rankin, E. M.; Wolf, C. R. In silico prediction of drug binding to CYP2D6: Idetification of a new metobolite of metoclopramide Drug Metab. Dispos. 2006, 34, 1386-1392
42. Desta, Z.; Wu, G. M.; Morocho, A. M.; Flockhart, D. A. The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6 Drug Metab. Dispos. 2002, 30, 336-343
43. Kobayashi, K.; Nakajima, M.; Oshima, K.; Shimada, N.; Yokoi, T.; Chiba, K. Involvment of CYP2E1 as a low-affinity enzyme in phenacetin O-deethylation in human liver microsomes Drug Metab. Dispos. 1999, 27, 860-865
44. Yokono, A.; Morpta, S.; Someya, T.; Hirokane, G.; Okawa, M.; Shimoda, K. The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients J. Clin. Psychopharm. 2001, 21, 549-555
45. Islam, S. A.; Wolf, C. R.; Lennard, M. S.; Sternberg, M. J. E. A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation Carcinogenesis 1991, 12, 2211-2219
46. Venhorst, J.; Laak, A. M.; Commandeur, J. N. M.; Funae, Y.; Hiroi, T.; Vermeulen, N. P. E. Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities J. Med. Chem. 2003, 46, 74-86
47. Bharucha, A. E.; Skaar, T.; Andrews, C. N.; Camilleri, M.; Philips, S.; Seide, B.; Burton, D.; Baxter, K.; Zinsmeister, A. R. Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects Neurogastroenterol. Motil. 2008, 20, 891-899